About Us
Jeffrey M. Bockman, PhD
Vice President
jbockman@definedhealth.com
Jeff’s scientific expertise encompasses a broad range of therapeutic disciplines
for which he serves as Team Leader or internal consultant, including Oncology,
Infectious Disease (especially HIV, hepatitis, and antibiotic-resistant
bacterial infections), Inflammatory Disorders (especially asthma and psoriasis),
Complex Therapeutics (cell and gene therapy) and Drug Delivery. Jeff also has
extensive commercial and strategic perspective on the pharmaceutical and biotech
industries. He has directed hundreds of in-depth licensing opportunity and
valuation assessments during his tenure at DH.
Before joining Defined Health, Jeff was a Senior Research Scientist and Research Project Leader in the commercial development of oligonucleotide therapeutics for viral diseases and cancer at Innovir Laboratories; and an Assistant Research Professor at The George Washington University School of Medicine. He has worked with two Nobel Prize recipients: Dr. Sidney Altman on ribozymes, and Dr. Stanley Prusiner on prions, and holds four patents in applications of ribozymes as therapeutics and diagnostics.
Jeff is a member of the Licensing Executives Society and the American Association for Cancer Research. He received a BA from University of California at San Diego, a PhD in Medical Microbiology from the University of California at Berkeley, and an MA in English/Creative Writing from New York University.
With his wife he founded and has been running for over ten years a well-regarded
literary journal, Literal Latte. Jeff continues to write fiction, essays and
book reviews that he publishes in various literary magazines.